PrimePro

N/A

Report date: 2023/01/12 15:46:46

Base Information

Drug NamePrimePro
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Autoimmune DiseasesDiabetes Complications +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThomas Advanced Medical LLC
China Registration ClassN/A

Develop Information

Active CompaniesThomas Advanced Medical LLC
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDiabetes ComplicationsSkin Diseases +[8] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Cardiovascular DiseasesNervous System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A